Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Turning Point Therapeutics Inc.
Sponsor

Turning Point Therapeutics Inc.

United States Route 206 And Province Line Road, 08543, United States

About the sponsor

Turning Point Therapeutics Inc. focuses on advanced solid tumors, with clinical research centered on metastatic malignancies and genetically defined cancer populations.

  • Advanced solid tumors
  • Metastatic malignancies
  • Genomic oncology

The sponsor’s clinical portfolio reflects a strong interest in identifying targeted treatment options for difficult-to-treat tumor types.

About Specializations

Turning Point Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neoplasm

Recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Repotrectinib
  • Sponsor:Turning Point Therapeutics Inc.

Neoplasm

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Repotrectinib
  • Sponsor:Turning Point Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.